US health care company Perrigo (NYSE: PRGO) revealed this morning that Ireland-based drugmaker Elan Corp (NYSE: ELN) has entered into a definitive agreement to 29 July 2013
Generic drugmaker Perrigo (NYSE: PRGO) says it has signed a definitive agreement to acquire and has completed the acquisition of an ophthalmic sterile ointment 18 June 2013
Denmark-based Novo A/S, the holding company of the Novo Group and the major shareholder in Novo Nordisk and Novozymes, has purchased all shares of the Norwegian 21 May 2013
US generic major Actavis (NYSE: ACT) has entered into an agreement with privately-held Purdue Pharma to settle all outstanding patent litigation related to Acta 29 April 2013
Further to its announcement last month that it was undertaking a review of the strategic options for its global Injectables business (The Pharma Letter March 4) 17 April 2013
German family-owned firm Merz Pharma has written to the board of director of Obagi Medical Products outlining a proposal to acquire all of the outstanding commo 2 April 2013
The Indian patent office has again ruled in favor of domestic drugmaker Cipla (BSE: 500087), reinstating its earlier decision to revoke pharma behemoth Pfizer's 12 February 2013
South Africa's largest health care company Adcock Ingram (AIP: SJ) has announced the completion of the acquisition of Cosme Farma Laboratories, a pan-Indian pha 22 January 2013
The biggest non-event in the Japan health care market during 2013 will be no reimbursement price reductions, comments P Reed Maurer, long-time Japanese pharma i 3 January 2013
US drugmaker Perrigo (Nasdaq: PRGO; TASE) announced on Friday that it has signed a definitive merger agreement and has completed the acquisition of Cobrek Pharm 31 December 2012
Dublin, Ireland-based sales, marketing, distribution and business support services group DCC, says that its DCC Healthcare unit has reached conditional agreemen 24 December 2012
Want to acquire a Japanese pharmaceutical company? Join the back of a long line of companies with the same objective. There is no shortage of willing buyers, bu 18 December 2012
Japan's largest drugmaker, Takeda Pharmaceutical (TYO: 4502), has entered into a definitive agreement with Caraco Pharmaceutical Laboratories, a wholly-owned su 17 December 2012
Anglo-Swedish drug major AstraZeneca (LSE: AZ) said on Friday that the US Court of Appeals for the Federal Circuit has upheld the decision of the District Court 17 December 2012
Finland-based water chemistry specialist Kemira Oyj (OMX: KRA1V) has signed an agreement to sell its food and pharmaceutical businesses together with its acetat 16 December 2012
Indian drugmaker Elder Pharmaceuticals says it is ready to enter the European Union market following receipt of Certificate of Suitability (CoS) from European D 26 November 2012
Impax Laboratories (Nasdaq: IPXL) said yesterday that it plans to collaborate with fellow US drugmaker Perrigo (Nasdaq: PRGO) on the development, manufacturing 22 November 2012
USA-based Validus Pharmaceuticals (NYSE: VR) together with Wood Creek Capital Management, have acquired USs rights to six well-known product lines, patent prote 19 November 2012
US specialty drugmaker Pernix Therapeutics (NYSE: PTX) has entered into a definitive agreement to acquire privately-held Cypress Pharmaceuticals, a maker of gen 15 November 2012
USA-based Insmed (NASDAQ CM: INSM) is a biopharmaceutical company on the development and commercialization of novel, targeted inhaled therapies for patients with serious rare diseases.
Sign up to receive email updates Join industry leaders for a daily roundup of biotech & pharma news